Expression of human pro-matrix metalloproteinase 3 that lacks the N-terminal 34 residues in Escherichia coli autoactivation and interaction with tissue inhibitor of metalloproteinase 1 (TIMP-1)

Biological Chemistry

Volumn 379, Issue 2, 1998, Pages 185-191

  Suzuki, Ko ^a   Kan, Chen Chen ^b   Hung, Wen ^c   Gehring, Michael R ^b   Brew, Keith ^c   Nagase, Hideaki ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b AGOURON PHARMACEUTICALS INC   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Extracellular matrix; Stromelysin; TIMP; Zymogen activation

Indexed keywords

CALCIUM ION; METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; ZINC ION;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVATION; ESCHERICHIA COLI; EXTRACELLULAR MATRIX; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ESCHERICHIA COLI;

EID: 0031883960     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/bchm.1998.379.2.185     Document Type: Article

References (35)

1. Becker, J.W., Marcy, A.I., Rokosz, L.L., Axel, M.G., Burbaum, J.J., Fitzgerald, P.M.D., Cameron, P.M., Esser, C.K., Hagmann, W.K., Hermes, J.D., and Springer, J.R (1995). Stromelysin-1: Three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Protein Science 4, 1966-1976.
2. Benbow, U., Buttice, G., Nagase, H., and Kurkinen, M. (1996). Characterization of the 46-kDa intermediates of matrix metalloproteinase 3 (stromelysin 1) obtained by site-directed mutation of phenylalanine 83. J. Biol. Chem. 271, 10715-10722.
3. Cameron, P.M., Marcy, A.I., Rokosz, L.L., and Hermes, J.D. (1995). Use of an active-site inhibitor of stromelysin to elucidate the mechanism of prostromelysin activation. Bioorg. Chem. 23, 415-426.
4. Chen, L.-C., Noelken, M.E., and Nagase, H. (1993). Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase 3 (stromelysin 1). Biochemistry 32, 10289-10295.
5. Crabbe, T., O'Connell, J., Smith, B.J., and Docherty, A.J.P. (1994). Reciprocated matrix metalloproteinases activation: A process performed by interstitial collagenase and progelatinase A. Biochemistry 33, 14419-14425.
6. DeClerck, Y.A., Yean, T.-D., Lu, H.S., Ting, J., and Langley, K.E. (1991). Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J. Biol. Chem. 266, 3892-3899.
7. Freimark, B.D., Feeser, W.S., and Rosenfeld, S.A. (1994). Multiple sites of the propeptide region of human stromelysin-1 are required for maintaining a latent form of the enzyme. J. Biol. Chem. 269, 26982-26987.
8. Galazka, G., Windsor, L.J., Birkedal-Hansen, H., and Engler, J.A. (1996). APMA (4 aminophenylmercuric acetate) activation of stromelysin 1 involves protein interactions in addition to those with cysteine 75 in the propeptide. Biochemistry 35, 11221-11227.
9. Holz, R.C., Salowe, S.P., Smith, C.K., Cuca, G.C., and Que, L., Jr. (1992). EXAFS evidence for a 'cysteine switch' in the activation of prostromelysin. J. Am. Chem. Soc. 114, 9611-9614.
10. Housley, T.J., Baumann, A.P., Braun, I.D., Davis, G., Seperack, P.K., and Wilhelm, S.M. (1993). Recombinant Chinese hamster ovary cell matrix metalloprotease-3 (MMP-3, stromelysin-1). Role of calcium in promatrix metalloprotease-3 (pro-MMP-3, prostromelysin-1) activation and thermostability of the low mass catalytic domain of MMP-3. J. Biol. Chem. 268, 4481-4487.
11. Huang, W., Suzuki, K., Nagase, H., Arumugam, S., Van Doren, S.R., and Brew, K. (1996). Folding and characterization of the amino-terminal domain of human tissue inhibitor of metalloproteinases-1 (TIMP-1) expressed at high yield in E coli. FEBS Lett. 384, 155-161.
12. Imai, K., Yokohama, Y., Nakanashi, I., Ohuchi, E., Fujii, Y., Nakai, N., and Okada, Y. (1995). Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J. Biol. Chem. 270, 6691-6697.
13. Itoh, Y., Binner, S., and Nagase, H. (1995). Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP-2) by 4-aminophyenylmercuric acetate. Biochem. J. 308, 645-651.
14. Kan, C.C., Gehring, M.R., Nodes, B.R., Janson, C.A., Almassy, R.J., and Hostomska, Z. (1992). Heterologous expression and purification of active human phosphoribosylglycinamide formyl-transferase as a single domain. J. Protein Chem. 11, 467-473.
15. r active forms, and a comparison of recombinant with natural stromelysin activities. Biochem. J. 276, 217-221.
16. Matsudaira, P. (1987). Sequence from picomole quantities of proteins electroblotted onto polyvinylidene dif luoride membranes. J. Biol. Chem. 262, 10035-10038.
17. Murphy, G., and Willenbrock, F. (1995). Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol. 248, 496-510.
18. Nagase, H. (1995). Human stromelysin 1 and 2. Methods Enzymol. 248, 449-470.
19. Nagase, H. (1996). Matrix metalloproteinases. In: Zinc Metalloproteases in Health and Disease, N.M. Hooper, ed. (London, England: Taylor and Francis), pp. 153-204.
20. Nagase, H. (1997). Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378, 151-160.
21. Nagase, H., Enghild, J.J., Suzuki, K., and Salvesen, G. (1990). Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate. Biochemistry 29, 5783-5789.
22. Ogata, Y., Itoh, Y., and Nagase, H. (1995). Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases. J. Biol. Chem. 270, 18506-18511.
23. Okada, Y., Nagase, H., and Harris, E.D., Jr. (1986). A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J. Biol. Chem. 261, 14245-14255.
24. Okada, Y., Harris, E.D., Jr., Nagase, H. (1988). The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate. Biochem. 254, 731-741.
25. Riddles, P.W., Blakeley, R.L., and Zerner, B. (1979). Ellman's Reagent: 5,5′-Dithiobis(2-nitrobenzoic acid)-a reexamination. Anal. Biochem. 94, 75-81.
26. Salowe, S.P., Marcy, A.I., Cuca, G.C., Smith, C.K., Kopka, I.E., Hagmann, W.K., and Hermes, J.D. (1992). Characterization of zinc-binding sites in human stromelysin-1: stoichiometry of the catalytic domain and identification of a cysteine ligand in the proenzyme. Biochemistry 31, 4535-4540.
27. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning. A Laboratory Manual, (Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press).
28. Saus J., Quinones, S., Otani, Y., Nagase, H., Harris, E.D., Jr., and Kurkinen, M. (1988). The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin. J. Biol. Chem. 263, 6742-6745.
29. Schoner, B.E., Belagaje, R.M., and Schoner, R.G. (1986). Translation of a synthetic two-cistron mRNA in Escherichia coli. Proc. Natl. Acad. Sci. USA 83, 8506-8510.
30. 73 active-site zinc complex in latency and a 'cysteine switch' mechanism for activation. Proc. Natl. Acad. Sci. USA 87, 364-368.
31. Suzuki, K., Enghild, J.J., Morodomi, T., Salvesen, G., and Nagase, H. (1990). Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29, 10261-10270.
32. Ward, R.V., Hembry, R.H., Reynolds, J.J., and Murphy, G. (1991). The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinasecomplex. Biochem. J. 278, 179-187.
33. Woessner, J.F., Jr. (1994). The family of matrix metalloproteinases. Ann. N.y. Acad. Sci. 732, 11-21.
34. Ye, Q.-Z., Johnson, L.L., Hupe, D.J., and Baragi, V. (1992). Purification and characterization of the human stromelysin catalytic domain expressed in Escherichia coli. Biochemistry 31, 11231-11235.
35. Zhu, X.L., Ohta, Y., Jordan, F.,and Inouye, M. (1989). Pro-sequence of subtilisin can guide the refolding of denatured subtilisin in an intermolecular process. Nature 339, 483-484.